Cancer has no chance. The discovery that sets the medical world on fire

Researchers around the world are looking for treatments to overcome this disease, which continues to kill millions of people every year.

The British National Health Service (NHS) says it will conduct a pilot program for a test that can quickly detect more than 50 different types of cancer, a test that could help thousands of people and help better treat cancer in its early stages.

The “Galleri” blood test was developed by a Californian company, Grail, and will be used for the first time for 165,000 patients, the NHS said in a news release Friday. Grail, whose work focuses on solutions for early cancer detection, is supported by American billionaires like Bill Gates or Jeff Bezos.

NHS experts say blood tests could be extremely helpful in identifying cancers that are difficult to diagnose and treat early – “Early detection, especially for difficult-to-treat cancers, such as ovarian or pancreatic cancer, has the potential to save many. more than 1,000 people are diagnosed with cancer every day in the UK, “said NHN Executive Director Simon Stevens, quoted by CNN.

The pilot program for the use of this new test will start in the middle of next year and will involve 165,000 people, of which 140,000 between the ages of 50 and 79 who have no symptoms but will be tested in three years.

The other 25,000 will be people with possible symptoms of cancer for whom tests will be used to detect the disease more quickly.

Final results are expected by 2023 and by 2025 the test will be widely used. Grail said in a statement that, based on the data obtained, “the use of Galleri has the potential to halve the number of terminal cancer diagnoses, which would significantly reduce the number of deaths from this disease in the UK by nearly. a fifth “.

However, not all oncologists believe the NHS should carry out this pilot program. Paul Pharoah, a professor at Cambridge University, says he has doubts about the effectiveness of this test, in the context of the limited data that have been published. Other experts believe that more tests should be carried out before starting the pilot program and that current scientific evidence certainly does not prove that the test has the ability to detect early stage cancer.